(1553010) Bruton tyrosine kinase inhibitor ibrutinib induces hypertension by upregulating transcription of CaV1.2 calcium channel

Primary Author(s)

• JW

  Juejin Wang, MD, PhD

  Head of Department
  Nanjing Medical University
  Nanjing, China (People's Republic)

Co-Author(s)

• SY

  Shumin Yin, N/A

  Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University
  Nanjing, China
• FL

  Feiran Liu, N/A
• LZ

  Ludan Zhang, N/A
• XS

  Xingyu Song, N/A
• WH

  Wei Hou, N/A
• XX

  Xiaoqing Xiong, PhD

  Nanjing Medical University
  Nanjing, China (People's Republic)
• JL

  Jianyong Li, MD, PhD

  Chief of Hematology department
  Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
  Nanjing, China (People's Republic)

Primary Author; Presenting Author(s)

• 

  Huayuan Zhu, MD

  the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
  Nanjing, China (People's Republic)